Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
The position of the Welsh Office was generally perceived as "being on all fours with that of the Department of Health" in relation to the HIV litigation.
Published on:
29 July, 2024
David Hunt, Secretary of State for Wales, wrote a letter to David Mellor, Chief Secretary to the Treasury, supporting the proposal for a settlement through the MacFarlane Trust.
Published on:
29 July, 2024
Peter Davenport of the Welsh Office wrote to ministers that the Department of Health had requested the views of territorial departments on the Haemophilia Society's campaign for parity between those infected with HCV and HIV.
Published on:
29 July, 2024
A draft letter from Welsh Office Health Service officials outlined concerns associated with compensating those infected with Hepatitis C, however it acknowledged that some form of "no-fault" compensation "may be inevitable".
Published on:
29 July, 2024
In response to a written parliamentary question, Welsh Office Minister Jon Owen Jones maintained that Government policy was that people infected with Hepatitis C through NHS treatment "should not receive special payments".
Published on:
29 July, 2024
In a memo from Sue Paterson to the new minister for Health and Social Services in the Welsh Government regarding Hepatitis C compensation, it was strongly advised that Wales maintain "the Government position on no-fault compensation".
Published on:
29 July, 2024
In a memo from Sue Paterson to the minister for Health and Social Services in the Welsh Government regarding Hepatitis C compensation, a line to take was suggested: people with haemophilia infected with Hepatitis C through NHS treatment received the "best available treatment at the time".
Published on:
29 July, 2024
The Minister for Health and Social Services in the Welsh Government wrote that there were no plans to make payments to those infected with Hepatitis C on the grounds that they received the best treatment available at the time.
Published on:
29 July, 2024
A paper entitled "Safety of Blood and Blood Products" provided to the Health and Social Services Committee stated that a UK inquiry was unlikely to provide a satisfactory answer and maintained the Welsh Assembly and UK Government position that no compensation was to be paid.
Published on:
29 July, 2024
A letter from Jane Hutt, Minister for Health and Social Services to David Lloyd stated that Welsh Assembly Government policy remained that compensation was only to be paid to patients when the NHS was at fault.
Published on:
29 July, 2024
Jane Hutt, Minister for Health and Social Services, wrote to Jan Wallace, Secretary of Haemophilia Wales, explaining that the Welsh Assembly had no plans to review or extend the special payments scheme.
Published on:
29 July, 2024
A draft letter from the Welsh Assembly Government to Haydn Lewis stated that the position remained that no compensation was to be paid to those "inadvertently" infected with Hepatitis C, as they received the best available treatment at the time.
Published on:
29 July, 2024
Jane Hutt wrote to Haydn Lewis stating that the Irish compensation scheme was being set up following evidence of negligence by the Irish Blood Service, but "that blood services in the UK have not been found to be similarly at fault."
Published on:
29 July, 2024
Jane Hutt maintained the decision not to support a public inquiry stating that all of the relevant information was already in the public domain.
Published on:
29 July, 2024
In R (March) v Secretary of State for Health, the judgment refers to the Irish compensation scheme and notes that it was put in place on compassionate grounds "without legal liability on the part of the State".
Published on:
29 July, 2024
Following review by the Welsh Secretary of State, John Redwood, a draft letter from Welsh Office Health Service officials no longer accepted that "no-fault" compensation might be inevitable.
Published on:
29 July, 2024
In a paper Dr Fowler questioned the theory of a single unknown virus and postulated that "haemophiliac AIDS may require years of repeated treatment with large quantities of concentrate [and so] be a function of the concentrate itself rather than a specific agent transmitted by homosexuals with or 'incubating' AIDS".
Published on:
23 July, 2024
Professor Bartlett in his oral evidence to the Archer Inquiry recalled that Dr Galbraith repeated his advice orally to the CSM(B). He commented further that although there were, by May 1983, only a small proportion of recipients of Factor 8 concentrate who had developed AIDS "the risk may not have been small" and added that "I think this last piece of evidence about the risk is one where other experts at the time disagreed".
Published on:
23 July, 2024
Professor Tedder stated "in veterinary medicine, products from one country would not get through incoming Customs of another country in the way that concentrates have come into the human market for haemophiliacs in the UK".
Published on:
23 July, 2024
Lord Glenarthur's office asked for a "fairly full draft letter" to respond to a parliamentary question asked by Baroness Masham. The draft response from the Department included the note that "we have confirmed with American manufacturers that future supplies of Factor VIII for this country will be manufactured only from plasma collected in accordance with US Food and Drug Administration Regulations introduced in March this year".
Published on:
23 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2219
Page
2220
Page
2221
Page
2222
Current page
2223
Page
2224
Page
2225
Page
2226
Page
2227
…
Next page
Next
Last page
Last